S&P 500
$5,958.38
+0.7%
+$41.45
DJI
$42,654.74
+0.8%
+$331.99
NASDAQ
$19,211.10
+0.5%
+$98.78
Bitcoin
$102,857.00
-1.2%
-$1,269.73
AAPL
$211.31
-0.1%
-$0.14
AMZN
$205.54
+0.2%
+$0.37
GOOG
$167.32
+1.2%
+$1.92
META
$640.11
-0.6%
-$3.77
MSFT
$453.88
+0.2%
+$0.75
NVDA
$135.20
+0.3%
+$0.38
TSLA
$349.44
+1.9%
+$6.62
Sohm (OTC: SHMN)
$0.00
(14.3%)
$0.00
Price as of May 16, 2025, 2:10 p.m. ET
Sohm Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Sohm Company Info
SOHM, Inc. engages in the manufacture and marketing of generic drugs. It develops generic pharmaceuticals in dosage forms, including tablets and capsules, creams and topical, ointments, liquids and injectable. Its products include analgesics, anticancer drugs, antifungals, dermatological, gastrointestinal and respiratory drugs, biotechnology products, immunosuppressive agents, ophthalmic drugs, and treatments for benign prostatic hyperplasia. The company was founded in 1998 and is headquartered in Chino Hills, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.